What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News We present the VHIR Annual Report 2022 It highlights the scientific and institutional results of the center during 2022. News Vall d'Hebron points to the usefulness of smartwatches as a complementary tool to medical care to detect arrhythmias after stroke Smartwatches are a practical, low-cost, noninvasive method that helps in the early detection of atrial fibrillations in some patients, which increase the risk of recurrent stroke. News Dr. Sara Marsal wins a trifermed award for Social Impact in Healthcare The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field. News SYNLAB and Vall d'Hebron sign collaboration agreement to promote medical research It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy. Activities Clone of Vall d'Hebron Talks 'Prevenció combinada del VIH: PrEP, PEP i TasP' Ponents: Dr. Vicente Descalzo, facultatiu del Servei d'Infeccioses de l'Hospital Universitari Vall d'Hebron i investigador del Grup de Recerca de Malalties Infeccioses del Vall d'Hebron Institut de Recerca (VHIR) CV: metge internista, adjunt a la unitat ITS-VIH Drassanes Vall Activities Clone of Vall d'Hebron Talks 'Prevenció combinada del VIH: PrEP, PEP i TasP' Ponents: Dr. Vicente Descalzo, facultatiu del Servei d'Infeccioses de l'Hospital Universitari Vall d'Hebron i investigador del Grup de Recerca de Malalties Infeccioses del Vall d'Hebron Institut de Recerca (VHIR) CV: metge internista, adjunt a la unitat ITS-VIH Drassanes Vall News Two Vall d’Hebron studies receive grants to study the benefit of exercise in bariatric surgery The research has received funding from the Spanish Society of Obesity Surgery and the Spanish Association of Surgeons. Activities Vall d'Hebron Talks by VHIR 'Diferential dietary regulation of proliferation of liver cells in cancer and regeneration' Speaker: Dr. Manuel Fernández Rojo, Group leader of the Hepatic Regenerative Medicine Group. Madrid Institute for Advanced Studies, IMDEA In the Hepatic Activities Vall d'Hebron Talks 'Prevenció combinada del VIH: PrEP, PEP i TasP' Ponents: Dr. Vicente Descalzo, facultatiu del Servei d'Infeccioses de l'Hospital Universitari Vall d'Hebron i investigador del Grup de Recerca de Malalties Infeccioses del Vall d'Hebron Institut de Recerca (VHIR) CV: metge internista, adjunt a la unitat ITS-VIH Drassanes Vall Activities TEST - Vall d'Hebron Talks 'Prevenció combinada del VIH: PrEP, PEP i TasP' Ponents: Dr. Vicente Descalzo, facultatiu del Servei d'Infeccioses de l'Hospital Universitari Vall d'Hebron i investigador del Grup de Recerca de Malalties Infeccioses del Vall d'Hebron Institut de Recerca (VHIR) CV: metge internista, adjunt a la unitat ITS-VIH Drassanes Vall News Vall d’Hebron coordinates the ENROL project to promote research on rare haematological diseases Recently, a closing meeting was organised to wrap up the first phase of the study, which aims at grouping sufficient data of patient affected by these pathologies. Activities Vall d'Hebron Talks by VHIR 'Unveiling molecular mechanisms behind metastasis in Gastrointestinal Stromal Tumor' Speaker: Aldo Di Vito, predoctoral researcher Translational Molecular Pathology (VHIR) Metastasis, the process through which tumor cells can colonize distant tissues, represents the leading cause of cancer-related death, including in Gastrointestinal stromal tumors (GISTs). Even if meta Activities Defensa de tesi 'Noves estratègies no antibiòtiques pel tractament d'infeccions causades per microorganismes multiresistents i creixent en biopel·lícules' Doctoranda: Marta Palau Gauthier, grup de Recerca d'Infeccioses i Inmunologia Pediatrica (VHIR) Directors: Dr. Joan Gavaldà Santapau i Dr. Benito Almirante Gragera. Tutor: Dr. Vicenç Falcó Ferrer News Barcelona has hosted the 6th World Parkinson's Congress Dr. Miquel Vila, head of the Neurodegenerative Diseases research group at VHIR, was the co-chair of the local organising committee. And Dr. Ariadna Laguna, principal investigator of the same group, was a scientific ambassador. News VHIR leads a gene therapy study to stop the progression of neurodegenerative diseases This gene therapy protects mice against cognitive deficits associated with aging, improves motor function, and delays the onset of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease. Activities Vall d'Hebron Talks by VHIR 'Air quality systems and climate predictions, tools developed at the Barcelona Supercomputing Center for their application in biomedicine' Speaker: Albert Soret Miravet, Earth System Services Group Leader at the Barcelona Supercomputing Center (BSC). It is widely known that climate change and air quality have an impact on different aspects of human health, but Activities Defensa de tesi 'Cribratge de preeclàmpsia de primer trimestre: validació, aplicació i detecció dels falsos positius' Doctoranda; Erika Bonacina, grup de Recerca de Medicina maternal i fetal (VHIR) Director: Dr. Manel Mendoza Tutor: Dr. Antonio Gil Moreno News Dr Xavier Montalban wins the MS Charcot Award, the highest international recognition in the treatment and research of multiple sclerosis This is the most prestigious international award in the multiple sclerosis scientific and social community, given in recognition of life-long work in care, research and teaching in relation to the disease. News Vall d'Hebron trains future professionals in the use of gene therapy to treat rare neurological disorders Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice. News Vall d'Hebron participates in the study that finds the first genetic variant related to the progression of multiple sclerosis The finding opens the door to the development of new therapies that block neurodegeneration, beyond current treatments that focus on the inflammatory process and the control of relapses. Pagination First page « Previous page ‹ … Page 27 Page 28 Current page 29 Page 30 Page 31 … Next page › Last page »
